Mixed specifications from Asia and weak ZEW data put pressure on the buying mood today. In addition, there are still no signs of an agreement on a further US economic stimulus program. After the sprint of around 700 points in seven trading days, some investors took profits and temporarily pushed the index below 13,000 points. There were minus signs not only in Germany, but in large parts of Europe. The EuroStoxx®50 went down almost one percent and closed at 3,270 points
The weakness in the stock market was reflected in the bond market today. The yield on 10-year Bunds fell to -0.55 percent and the yield on comparable US papers fell four points to 0.78 percent. The minus signs also ruled the precious metals. The gold price fell below the $ 1,900 mark. Palladium and silver fell over three percent to 2,320 and 24.10 US dollars per troy ounce, respectively. Oil stabilized within yesterday’s range. The price of a barrel of Brent Crude closed at around US $ 42.30.
Company in focus
At BayerThe bears continue to hold the reins of the shares. The profit warning was still in the bones of investors. The Deutsche Bank was able to stand against the trend today and book a small plus. Support came from the major shareholder Personal-Financial.com Group, who increased its stake. Evotec was one of the biggest winners in the MDAX today. With the Abi Dhabi state fund, the biotechnology group has a new major shareholder after the capital increase. Fraport sagged after weak passenger numbers. At HeidelbergCement some investors took profits after the recent rally, pushing the price down around 2.4 percent. HelloFresh benefited from positive analyst comments and set course for an all-time high. MorphoSys wants to place a convertible bond. The announcement was not well received by investors. Rather, the paper sank below the EUR 100 mark ThyssenKrupp According to various reports, there is speculation about a state entry. This idea met with little enthusiasm among investors.
The US companies Citigroup, Johnson & Johnson and JP morning reported good figures for the past quarter. Johnson & Johnson stock dipped nonetheless. The group must now also interrupt a study for a future corona vaccine due to illness of a subject. AstraZeneca shares fared similar recently, which had to put their vaccine study on hold.
Presented tonight Apple probably the new iPhone. Tomorrow report among other things Alcoa, Bank of America, Goldman Sachs and Wells Fargo over the past fiscal quarter.
- Europe – Euro zone industrial production, August
Chart technical outlook
Resistance marks: 13,100 / 13,170 / 13,250 points
Support marks: 12,970 / 13,000 points
The DAX® went into reverse today and temporarily touched the 38.2% retracement line. By the end of trading, however, the index had improved up to the 50% line. Above 13,000 points, the bulls could regain the upper hand and the index to 13,045 and then up to 13,100 points. The late recovery towards close of trading gives reason to be cautiously optimistic. Below 12,970 points, however, the next wave of sales threatens.
DAX® in points; Hourly chart (1 candle = 1 hour)
Observation period: 14.09.2020 – 13.10.2020. Historical considerations are not reliable indicators for future developments. Source: tradingdesk.onemarkets.de
DAX® in points; Weekly chart (1 candle = 1 week)
Observation period: October 14, 2013 – October 13, 2020. Historical considerations are not reliable indicators for future developments. Source: tradingdesk.onemarkets.de
Inline warrants on the DAX®
|Underlying||WKN||Selling price in euros||Lower knock-out barrier in Pt.||Upper knock-out barrier in pt.||Final Valuation day|
|DAX®||HR03N7||7.38||12,000||15,100||December 17, 2020|
Source: HypoVereinsbank onemarkets; Status: October 13, 2020; 5:45 pm
You can find information about how inline warrants and numerous other products work here at onemarkets knowledge. You will find leverage and investment products for speculation on an upward or downward movement or sideways movement of the DAX® here.
NEW: Cashback trading – when the issuer pays my order fees!
Please note the important information and the disclaimer.
This information does not constitute investment advice, but advertising. The public offer is made exclusively on the basis of a securities prospectus approved by the Federal Financial Supervisory Authority (“BaFin”). Approval of the prospectus should not be understood as a recommendation to purchase these UniCredit Bank AG securities. Only the prospectus including any supplements is relevant and the Final Terms. It is recommended that you read these documents carefully before making any investment decision in order to fully understand the potential risks and opportunities when making an investment decision. You are about to acquire a product that is not easy and can be difficult to understand.
How the HVB products work
The article Daily Outlook for October 14th: DAX with setback. Bayer and biotechs at a glance! first appeared on onemarkets blog (HypoVereinsbank – UniCredit Bank AG).
Author: Richard Pfadenhauer